ALGS vs TAP
Aligos Therapeutics Inc (ALGS) versus TAP (TAP) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
TAP (TAP) common stock.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
TAP does not have a complete income-statement cache yet.
ALGS currently screens at market cap $44.1M. TAP currently screens at market cap $0.
Not investment advice. Open the ALGS and TAP stock pages for the full models.
Not investment advice.